Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)

Clinical trial NCT00322556 · COMPLETED

Trial details

NCT number: NCT00322556
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Agammaglobulinemia IgG Deficiency Common Variable Immunodeficiency

Start date: 2005-11-01
Primary completion: 2008-04-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.